Evidence map›Paper›PMID 39623353›Full record

ArticleBMC public health2024

Barriers and facilitators of a large clinical trial on prevention of HIV transmission through breastfeeding in Lusaka, Zambia: a qualitative study.

Anaïs Mennecier, Beauty Matoka, Maria Melany Wilfred-Tonga, Catherine Chunda-Liyoka, Mwiya Mwiya, Nicolas Nagot, Jean-Pierre Molès, Philippe Van de Perre, Chipepo Kankasa, Rachel King and 1 more

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anaïs MennecierPathogenesis and Control of Chronic and Emerging Infections, Univ Montpellier, INSERM, EFS, Univ Antilles, Montpellier, France. anais.mennecier@inserm.fr.
Beauty MatokaPediatric Centre of Excellence, University Teaching Hospital, Lusaka, Zambia.
Maria Melany Wilfred-TongaPediatric Centre of Excellence, University Teaching Hospital, Lusaka, Zambia.
Catherine Chunda-LiyokaPediatric Centre of Excellence, University Teaching Hospital, Lusaka, Zambia.
Mwiya MwiyaPediatric Centre of Excellence, University Teaching Hospital, Lusaka, Zambia.
Nicolas NagotPathogenesis and Control of Chronic and Emerging Infections, Univ Montpellier, INSERM, EFS, Univ Antilles, Montpellier, France.
Jean-Pierre MolèsPathogenesis and Control of Chronic and Emerging Infections, Univ Montpellier, INSERM, EFS, Univ Antilles, Montpellier, France.
Philippe Van de PerrePathogenesis and Control of Chronic and Emerging Infections, Univ Montpellier, INSERM, EFS, Univ Antilles, Montpellier, France.
Chipepo KankasaPediatric Centre of Excellence, University Teaching Hospital, Lusaka, Zambia.
Rachel KingPathogenesis and Control of Chronic and Emerging Infections, Univ Montpellier, INSERM, EFS, Univ Antilles, Montpellier, France.
PROMISE-EPI social science sub-study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPROMISE-EPI trial evaluated a combination of interventions to prevent HIV transmission during breastfeeding. It showed a reduced postnatal transmission compared to the standard of care. The intervention combined identification of infants at high risk of infection using a point of care assay (POC) for early infant diagnosis and monitoring maternal viral load (VL) at 6 weeks and 6 months. A single-drug post-natal prophylaxis (PNP) was immediately initiated for high risk infants (maternal VL ≥ 1000 cp/mL). In Zambia, the national guidelines standard of care differs by 1) using three-drug PNP; 2) quarterly monitoring of maternal VL; 3) maternal VL testing in central labs. We explored the facilitators and barriers of this innovative prevention package to guide future scale-up.

methodsQualitative methods were used to gather information on PROMISE-EPI trial delivery, context, and behaviors. PROMISE-EPI intervention and control participants, staff members and health care professionals were interviewed. Verbatim transcripts were coded using a priori and emerging codes. Analysis was conducted using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework. The determinants were categorized into the 5 domains of the Consolidated Framework for Implementation Research (CFIR) to better identify the causes of intervention success or failure among the 5 RE-AIM components.

resultsA total of 37 individual interviews and 15 focus group discussions were conducted. Facilitators included the importance of the connection between the key elements of the intervention (POC and PNP) for immediate clinical action. Rapid maternal VL results induce several positive downstream behaviors in mothers and healthcare professionals, including increased trust in health care system. These can be quickly reversed when point of care testing is sub-optimal, as during the COVID-19 pandemic. Furthermore, the secondary elements of the intervention beyond POC and PNP; namely a warm welcome, a dedicated space, detailed and dedicated counselling, reimbursement for transport, solar panels and batteries, reminders and additional staff; were identified as facilitating its acceptability and fidelity.

conclusionThis study provides new elements to better understand the reduced HIV transmission with the PROMISE-EPI intervention. It also highlights potential gaps between the package proposed in the trial and what can be applied in less controlled, 'real life' settings.

Indexed as

Breast FeedingHIV InfectionsInfectious Disease Transmission, VerticalQualitative ResearchAdultFemaleHumansInfantInfant, NewbornMaleViral LoadZambiaAfricaBreast-feedingHIV preventionMTCTPoint-of-carePost-natal prophylaxisQualitativeVertical transmissionZambia

Identifiers

PMID39623353
PMCPMC11613839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.